[Edaily Reporter Jung-yo Lim]

“Mezoo will become the first Korean company to enter the U.S. market, which has the strongest demand in remote ECG monitoring. We aim to list on KOSDAQ with a market capitalization of around KRW 200 billion and demonstrate rapid growth.”

Jung-hwan Park, CEO of Mezoo, made the remarks in an interview with Edaily on the 29th at the company’s office in Gangnam, Seoul. Mezoo recently passed the technology evaluation after receiving grades of A and BBB from NICE D&B and Seoul Credit Rating & Information. The company plans to file for a preliminary KOSDAQ listing review in September and complete its IPO by January next year.